Protagonist Therapeutics Inc (PTGX)
EBITDA Margin
30.45%
TTM · Period ending:
PTGX EBITDA Margin
Latest reported30.45%period ending
Latest reported30.45%period ending
PTGX TTM EBITDA Margin (-517.22% → 30.45%)
TTM ebitda margin
High-resolution chart · PNG
PTGX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 30.4544% | |
| -153.8244% | |
| -278.2315% | |
| 23.6649% | |
| 26.535% | |
| 28.8666% | |
| 64.9819% | |
| 54.4388% | |
| 55.1438% | |
| 53.3896% | |
| -126.0717% | |
| -15,734.8079% | |
| -460.3514% | |
| -362.6854% | |
| -286.6481% | |
| -256.769% | |
| -452.1658% | |
| -430.1312% | |
| -290.0838% | |
| -212.3163% | |
| -215.8097% | |
| -225.1975% | |
| -398.2002% | |
| -3,422.7783% | |
| -31,892.2078% | |
| 55,311.1111% | |
| -3,695.6002% | |
| -216.1906% | |
| -134.9782% | |
| -74.9084% | |
| -59.9464% | |
| -101.9874% | |
| -186.8664% | |
| -517.219% |